Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2019
DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2019 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB: PBSV),...
Day: March 18, 2019
Cerecor Reports Fourth Quarter and Full Year 2018 Results
-Significant Advancement in Pipeline and Regulatory Milestones-Meets Increased 2018 Revenue Guidance-Announces Net Revenue Guidance of $20-22 Million for 2019 ROCKVILLE,...
Champions Oncology Reports Quarterly Revenue of $6.4 Million
Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019 HACKENSACK, NJ / ACCESSWIRE / March 18,...
Holistic Medicine Practice In Brooklyn NY Announces New Website Launch
BROOKLYN, NY / ACCESSWIRE / March 18, 2019 / Dr. Kamau Kokayi with Healing Health Services in Brooklyn, New York,...
Sterna Biologicals Holds Scientific Advisory Board Meeting at 14th Congress of ECCO to Advance Phase IIb Clinical Development Program of SB012 in Ulcerative Colitis
- Meeting included international key opinion leaders - Input provided on SB012 development plan and phase IIb trial protocol MARBURG,...
Ozop Surgical Corp Provides Corporate Update and Outlook for 2019
WEST PALM BEACH, FL / ACCESSWIRE / March 18, 2019 / Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium...
Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update
TORONTO, ON / ACCESSWIRE / March 18, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) Announces that it has filed...
Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute
Excellent Initial Flow Rates Achieved with CoreoGrafts for Bypasses Completed in Two Test Subjects IRVINE, CA / ACCESSWIRE / March...
WNDM Medical Inc. Acquires Remaining 50% Interest in Cellerate, LLC from an Affiliate of The Catalyst Group, Inc; Elects Ron Nixon to its Board of Directors
FORT WORTH, TX / ACCESSWIRE / March 18, 2019 / WNDM Medical Inc. (OTCQB: WNDM) Based in Fort Worth, Texas,...
AXT107 Restores Healthy, Non-Leaky Vasculature in the Eye by Inhibiting VEGFR2 and Activating Tie2, the Two Clinically Validated Pathways in Diseases of the Retina
AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor...
Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) Announces Entry into the CBD Market
SACRAMENTO, CA / ACCESSWIRE / March 18, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today its immediate entry...